Rational application of cyclophosphamide in kidney diseases

doi:10.3877/cma.j.issn.2095-3216.2014.04.007

Abstract

Abstract:

Cyclophosphamide is one of the most common cytotoxic drugs that has been used in therapies of many kinds of autoimmune diseases, anti-rejection after transplantation, and tumors since 1960s. Cyclophosphamide has also been applied in treatment of various pathological types of kidney diseases with substantial effects. In the process of its application, attention should be paid to its rationality as well as evaluation of its efficacy and side effects.

Key words: Cyclophosphamide, Kidney disease, Efficacy, Side effect

Zhiyong Guo, Rui Dong. Rational application of cyclophosphamide in kidney diseases[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2014, 03(04): 204-208.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2014.04.007

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2014/V03/I04/204

References 39

1	王海燕.肾脏病学[M]. 第3 版. 北京:人民卫生出版社, 2008:2206-2208.
2	韦凤华. 环磷酰胺临床应用研究进展[J]. 中国药事,2013,27(3):324-326.
3	陈新谦,金有豫,汤光.新编药物学[M]. 第15 版. 北京:人民卫生出版社,2003:664-665.
4	张晓峰.环磷酰胺口服致老年人急性肝损伤[J]. 药物不良反应杂,2005,7(6):41.
5	张利然.环磷酰胺致心律失常1 例[J]. 河北职工医学院学报,2007,24(2):6.
6	苏雷,高燕,陈航.环磷酰胺致多型红斑药疹1 例[J]. 医学研究与教育,2009,26(2):42.
7	柯志勇,赖峰,李菁,等. 大剂量环磷酰胺对儿童水、电解质及肾功能的影响[J].实用儿科临床杂志,2008, (3):208-210.
8	Balow JE,Bounpas DT,Fessler BJ,et al. Management of lupus nephritis [J].Kidney Int,1996,53(Suppl): S88-S92.
9	许慧丽,何永成.环磷酰胺冲击治疗在肾小球疾病中的应用及其副作用的防治[J]. 深圳中西医结合杂志,2005,15(4):208-210.
10	叶任高,李小萍,李惠群,等.改进的环磷酰胺冲击疗法治疗狼疮性肾炎观察[J].中华肾脏病杂志,1991,7(2):147.
11	Hsu AC,Folami AO,Bain J,et al.Gonadal function in males treated wi th eyclophosphamide for nephrotic syndrome [J]. Fertil Steril,1979,31(2):173-177.
12	Mok CC, Ho CT, Chan KW, et al. Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclophospharnide and azathioprine [J]. Arthritis Rheum,2002,46(4):1003-1013.
13	Ioannidis JP, Katsifis GE, Tzioufas AG, et al. Predictors of sustained amenorhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus [J]. J Rheumatol,2002,29(10):2129-2135.
14	Brenner BM. The Kidney [M]. 8th edition. Philadelphia, PA:Saunders,2007:1067-1148.
15	Saxena R, Mahajan T, Mohan C. Lupus nephritis: current update[J]. Arthritis Res Ther,2011,13(5):240.
16	Austin HA 3rd, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs [J]. N Engl J Med,1986,314(10):614-619.
17	Gourley MF, Austin HA 3rd, Scott D, et al. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized controlled trial [J]. Ann Int Med,1996,125(7):549-557.
18	Bono L, Cameron JS, Hicks JA. The very long-term prognosis and complications of lupus nephritis and its treatment [J]. QJM,1999,92(4):211-218.
19	Houssiau FA, Vasconcelos C, D'Cruz D, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide [J]. Arthritis Rheum, 2002, 46(8): 2121-2131.
20	Houssiau FA, D'Cruz D, Sangle S, et al. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial [J]. Ann Rheum Dis,2010,69(12):2083-2089.
21	Feehally J. Comprehensive clinical nephrology [M]. Buffalo, NY,USA: University of Buffalo,2007:295-309.
22	Wilcox C. Handbook of nephrology and hypertension [M]. Buffalo,NY, USA: Univeristy of Baffalo,2009:49-62.
23	du Buf-Vereijken PW, Branten AJ, Wetzels JF. Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy [J]. Am J Kidney Dis,2005,46(6):1012-1029.
24	Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy [J]. N Engl J Med,1989,320(4):210-215.
25	Cameron JS, Healy MJ, Adu D. The medical research council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC glomerulonephritis working party [J]. Q J Med, 1990, 74(274):133-156.
26	Ponticelli C, Altieri P, Scolari F, et al. A randomized study comparingmethylprednisolonepluschlorambucilversus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy [J]. J Am Soc Nephrol,1998,9(3):444-450.
27	Ponticelli C,Zucchelli P,Passerini P,et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy [J]. Kidney Int, 1995, 48(5): 1600-1604.
28	Jha V,Ganguli A,Saha TK,et al. A randomized,controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy [J]. J Am Soc Nephrol,2007,18(6):1899-1904.
29	du Buf-Vereijken PW, Branten AJ, Wetzels JF. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate [J]. Nephrol Dial Transplant, 2004,19(5):1142-1148.
30	Torres A, Dominguez-Gil B, Carreno A, et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy [J]. Kidney Int,2002,61(1):219-227.
31	Branten AJ, Reichert LJ, Koene RA, et al. Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency [J]. QJM,1998,91(5):359-366.
32	Kidney Disease: Improving Global Outcomes ( KDIGO )Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis [J]. Kidney Int Suppl, 2012, 2(2): 139-174.
33	Faurschou M, Sorensen IJ, Mellemkjaer L, et al. Malignancies in Wegener'sgranulomatosis:incidenceandrelationto cyclophosphamide therapy in a cohort of 293 patients [J]. J Rheumatol,2007,35(1):100-105.
34	Lahmer T, Heemann U. Anti-glomerular basement membrane antibody disease: a rare autoimmune disorder affecting the kidney and the lung [J]. Autoimmun Rev,2012,12(2):169-173.
35	陈书芬,刘志红,陈惠萍,等.激素联合环磷酰胺冲击治疗对新月体肾炎肾小球趋化因子的影响[J]. 中华医学杂志:英文版,2002,115(9):1301-1307.
36	Ren H,Shen P,Li X,et al. Tacrolimus versus cyclophosphamide in steroid-dependentorsteroid-resistantfocalsegmental glomerulosclerosis: a randomized controlled trial [ J]. Am J Nephrol,2013,37(1):84-90.
37	Wang W, Chen N. Treatment of progressive IgA nephropathy: an update [J]. Contrib Nephrol,2013,181:75-83.
38	Fang J, Li W, Li D, et al. Baseline proteinuria, urinary osmotic pressure, and renal function as positive predictors of corticosteroids plus cyclophosphamide treatment efficacy in IgA nephropathy [J].Chin Med J (Engl),2014,127(9):1710-1714.
39	Li H1, Shi X, Shen H, et al. Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label,nonrandomized cohort trial [J]. Clin Ther, 2012, 34(5): 1112-1120.

[1]	Jie Wang, Quan Yuan, Yueqi Wang, Jiajun Qiao, Chunli Tan, Zhongyuan Xia, Shouyao Liu. Observation on the application effect and safety of ulcer oil in the treatment of diabetic foot ulcer [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(06): 480-484.
[2]	Shengjun Nie, Yu Wang, Yi Wang, Xiaoqing Xian, Shengcheng Ma. Clinical effect observation of compound betamethasone local injection combined with photodynamic therapy for small keloids [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(05): 404-410.
[3]	Yuefang Xu, Wang Liu, Miaotian Zeng, Yushu Guo. Clinical efficacy of polymyxin B and polymyxin E in the treatment of surgical multi-drug resistant infections Security analysis [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(06): 700-703.
[4]	Qizhou Mo, Jin Su, Jian Huang, Jianwei Li, Sining Li, Jianjun Liu. Application of intelligent pressure-controlled flexible ureteroscopic suctioning lithotripsy in upper urinary tract stones with diameter of 10-25 mm [J]. Chinese Journal of Endourology(Electronic Edition), 2024, 18(05): 497-502.
[5]	Yiliang Li, Yakufu Sulayiman, Maimaitiming Maimaitiaili, Abudoureyimu Kelimu. An analysis of short-term outcomes of robotic-assisted versus conventional laparoscopic esophageal hiatal hernia repair combined with nissen fundoplication [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 512-517.
[6]	Yan Zhou, Ying Li, Xiaobing Zhou, Fahui Cheng, Hengzheng He. Efficacy of different types of mesh combined with Nissen fundoplication for repairing hiatal hernia and potential risk factors for recurrence [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 528-533.
[7]	Xiaoqin Wang, Li Wang, Jianying Cui. Effect of tension-free hernia repair in the treatment of patients with chronic renal failure complicated with inguinal hernia [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2024, 18(05): 538-542.
[8]	Yalan Wang, Jing Ni, Shiqing Yu, Yinhua Tao, Rong Zhang. Analysis of tolerance and efficacy factors of Nintedanib anti-fibrotic in the treatment of idiopathic pulmonary fibrosis [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(05): 750-755.
[9]	Yanping Liang, Shiyun Lie, Yisui Wang, Xiaoying Wu, Ying Lin. Establishment of standardized management regimen for endoscopic tissue glue injection for gastric varices based on endoscopic operation detail recording system [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(05): 705-709.
[10]	Jie Chen, Mingsheng Wu, Yijin Li, Hu Li, Yuanchu Xiang, Xinqi Rong, Jian Peng. Preliminary clinical study of cryotherapy for low rectal cancer [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2024, 13(06): 494-498.
[11]	Xuefeng Zhou, Zheyi Dong, Zhe Feng, Guangyan Cai, Xiangmei Chen. Formulation protocol of guidelines for diagnosis and treatment of diabetic kidney disease with integrated traditional Chinese and Western medicine [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 301-305.
[12]	Bin Shi, Yuan Si. Effect of Yiqiheluo formula combined with valsartan in the treatment of IgA nephropathy with deficiency of both qi and yin plus blood stasis syndrome [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 306-312.
[13]	Bokai Cheng, Guang Yang. Progress of research on application of hyperinsulinemic-euglycemic clamp technique for assessing insulin resistance in patients with chronic kidney disease [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2024, 13(06): 334-339.
[14]	Junling Han, Gang Wang, Liying Ma, Ying Lian, Hui Xu. Study on the therapeutic effect of vitamin D combined with povidone bromide tablets on diarrhea type patients with irritable bowel syndrome and its impact on intestinal barrier function indicators [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2024, 14(06): 560-564.
[15]	Peipei Xi, Jiajun Zhou. Progress in research of sarcopenia in patients with chronic kidney disease: pathogenesis, diagnosis, and treatment [J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 491-495.

Please choose a citation manager

Content to export